Search Orphan Drug Designations and Approvals
-
Generic Name: | Pegylated Liposomal Alendronate with Doxorubicin |
---|---|
Date Designated: | 11/08/2021 |
Orphan Designation: | Treatment of soft tissue sarcoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
LEVCO Pharmaceuticals Ltd. Shlomo Momo Halevi St. 5 Jerusalem, Israel 9777019 Israel The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-